Abstract:The increased synthesis of building blocks of IPP (isopentenyl diphosphate) and DMAPP (dimethylallyl diphosphate) through metabolic engineering is a way to enhance the production of carotenoids. Using E. coli as a host, IPP and DMAPP supply can be increased significantly through the introduction of foreign MVA (mevalonate) pathway into it. The MVA pathway is split into two parts with the top and bottom portions supplying mevalonate from acetyl-CoA, and IPP and DMAPP from mevalonate, respectively. The bottom portions of MVA pathway from Streptococcus pneumonia, Enterococcus faecalis, Staphylococcus aureus, Streptococcus pyogenes and Saccharomyces cerevisiae were compared with exogenous mevalonate supplementation for beta-carotene production in recombinant Escherichia coli harboring beta-carotene synthesis genes. The E. coli harboring the bottom MVA pathway of S. pneumoniae produced the highest amount of beta-carotene. The top portions of MVA pathway were also compared and the top MVA pathway of E. faecalis was found out to be the most efficient for mevalonate production in E. coli. The whole MVA pathway was constructed by combining the bottom and top portions of MVA pathway of S. pneumoniae and E. faecalis, respectively. The recombinant E. coli harboring the whole MVA pathway and beta-carotene synthesis genes produced high amount of beta-carotene even without exogenous mevalonate supplementation. When comparing various E. coli strains - MG1655, DH5alpha, S17-1, XL1-Blue and BL21 - the DH5alpha was found to be the best beta-carotene producer. Using glycerol as the carbon source for beta-carotene production was found to be superior to glucose, galactose, xylose and maltose. The recombinant E. coli DH5alpha harboring the whole MVA pathway and beta-carotene synthesis genes produced beta-carotene of 465mg/L at glycerol concentration of 2% (w/v).

Microbial Production of Mevalonate

Bioconversion of Methanol to Value-Added Mevalonate by Engineered Methylobacterium Extorquens Am1 Containing an Optimized Mevalonate Pathway

Microbial production of mevalonate by recombinant Escherichia coli using acetic acid as a carbon source

Microbial Biosynthesis of L-Malic Acid and Related Metabolic Engineering Strategies: Advances and Prospects

[Microbial synthesis of monoterpenoids: a review].

Combinatorial Pathway Optimization in Escherichia Coli by Directed Co‐evolution of Rate‐limiting Enzymes and Modular Pathway Engineering

Recent progress in metabolic engineering of Saccharomyces cerevisiae for the production of malonyl-CoA derivatives

Combinatorial Optimization of MEP Pathway to Improve β-Carotene Yield

Reassessing Acetyl‐CoA Supply and NADPH Availability for Mevalonate Biosynthesis from Glycerol in Escherichia coli

Combinatorial engineering of hybrid mevalonate pathways in Escherichia coli for protoilludene production

Metabolic engineering of microbes for monoterpenoid production

Strategies for microbial synthesis of high-value phytochemicals

L-valine production in Corynebacterium glutamicum based on systematic metabolic engineering: progress and prospects

Combinatorial expression of bacterial whole mevalonate pathway for the production of β-carotene in E. coli

Metabolic Engineering of Escherichia Coli for the Production of L-Homoserine

Metabolic engineering strategies for sesquiterpene production in microorganism

Recent Advances in Microbial Production of cis,cis-Muconic Acid

Metabolic engineering of microorganisms: general strategies and drug production

Metabolic Engineering of Shikimic Acid Biosynthesis Pathway for the Production of Shikimic Acid and Its Branched Products in Microorganisms: Advances and Prospects

Medium Redesign for Stable Cultivation and High Production of Mevalonate by Recombinant Methtylobacterium Extorquens AM1 with Mevalonate Synthetic Pathway

Advances in metabolic engineering for enhanced acetyl-CoA availability in yeast